Financial Summary (All financials)
| In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 |
| Revenues | 164.3 | 23.9 | 6.2 | 1.0 | 0.0 | 0.2 | 0.0 | 11.6 |
| Revenue growth | 587.4% | 287.0% | 499.6% | | -100.0% | | -100.0% | 64.8% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 17.4 |
| Gross profit | 164.3 | 23.9 | 6.2 | 1.0 | 0.0 | 0.2 | 0.0 | -5.8 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | | 100.0% | | -50.4% |
| Research and development | 205.4 | 109.3 | 45.7 | 35.9 | 41.4 | 44.0 | 29.5 | |
| General and administrative | 72.1 | 42.8 | 21.7 | 16.8 | 15.4 | 19.2 | 15.6 | 5.8 |
| EBIT | -113.2 | -128.2 | -90.4 | -60.7 | -59.7 | -63.0 | -45.1 | -17.4 |
| EBIT margin | -68.9% | -536.3% | -1463.0% | -5897.0% | | -34253.8% | | -150.4% |
| Pre-tax income | -112.7 | -120.5 | -88.9 | -60.2 | -59.5 | -62.8 | -47.9 | -18.5 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -112.7 | -120.5 | -88.9 | -80.3 | -59.5 | -62.8 | -48.1 | 0.0 |
| Net margin | -68.6% | -503.9% | -1438.7% | -7795.3% | | -34151.6% | | -0.2% |
| |
| Diluted EPS | ($1.52) | ($1.76) | ($1.60) | ($3.66) | ($2.87) | ($3.09) | ($3.00) | ($709.57) |
| Shares outstanding (diluted) | 74.2 | 68.4 | 55.6 | 21.9 | 20.7 | 20.3 | 16.1 | 0.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|